Open AccessParadox of Appropriate Implantable Cardioverter‐Defibrillator Therapy: Saving Lives But Revealing an Increased Mortality Risk
Author(s) -
Aleong Ryan G.,
Sauer William H.
Publication year - 2017
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.117.007087
Subject(s) - medicine , implantable cardioverter defibrillator , primary prevention , sudden cardiac death , secondary prevention , ventricular fibrillation , cardiac resynchronization therapy , cardiology , heart failure , ejection fraction , disease
At one time, implantation of an implantable cardioverter‐defibrillator (ICD) was reserved for those patients who survived sudden cardiac death (SCD) from ventricular arrhythmia and had a secondary‐prevention‐only indication. However, along with improvements in device technology and the implant